Dae Gon Ha

Work

Analyst Dae Gon Ha works at STIFEL and is focused on the Healthcare sector with 98 price targets and ratings documented since 2019 spanning on 16 stocks. Previously, Dae Gon Ha worked at BTIG. Analyst's average stock valuation to be materialised ratio is 18.33% with an average time for price targets to be met of 46.67 days.

Most recent stock forecast was given on AGTC, Applied Genetic Technologies Corporation at 24-Oct-2022.

Dae Gon Ha best performing recommendations are on RYTM (RHYTHM PHARMACEUTICALS, INC).
The best stock recommendation documented was for RYTM (RHYTHM PHARMACEUTICALS, INC) at 6/17/2022. The price target of $25 was fulfilled within 59 days with a profit of $21.06 (534.52%) receiving and performance score of 90.6.

Average potential price target upside

AVRO CCXI EDIT FOLD FRLN FULC AGTC FIXX ORTX EQ PRQR RARE RCKT VERV NTLA RYTM
AVRO CCXI EDIT FOLD FRLN FULC AGTC FIXX ORTX EQ PRQR RARE RCKT VERV NTLA RYTM